Daily stress and glycaemic control in Type 1 diabetes: individual differences in magnitude, direction, and timing of stress-reactivity

2004 ◽  
Vol 66 (3) ◽  
pp. 237-244 ◽  
Author(s):  
Afsane Riazi ◽  
John Pickup ◽  
Clare Bradley
Keyword(s):  
Type 1 Diabetes ◽  
Individual Differences ◽  
Glycaemic Control ◽  
Stress Reactivity ◽  
Daily Stress

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/mL in people with type 1 diabetes (EDITION 4)

2015 ◽  
Vol 10 (S 01) ◽  
Author(s):  
M Ziemen ◽  
RM Bergenstal ◽  
MC Riddle ◽  
M Rojeski ◽  
M Espinasse ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Insulin Glargine

Parental language proficiency and glycaemic control in children with type 1 diabetes

2018 ◽  
Author(s):  
Charlotte Jackson ◽  
Fiona Rutherford ◽  
Megan Shakesheff ◽  
Fiona Pinchin ◽  
Murray Bain ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Language Proficiency

Heterogeneous Long‐Term Trajectories of Glycaemic Control in Type 1 Diabetes

2021 ◽  
Author(s):  
Rachel G. Miller ◽  
Trevor J. Orchard ◽  
Suna Onengut‐Gumuscu ◽  
Wei‐Min Chen ◽  
Stephen S. Rich ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control

scholarly journals Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy

2020 ◽  
Vol 11 (6) ◽  
pp. 1369-1379 ◽  
Author(s):  
Benedetta Maria Bonora ◽  
Federico Boscari ◽  
Angelo Avogaro ◽  
Daniela Bruttomesso ◽  
Gian Paolo Fadini
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control

scholarly journals Glycaemic control by monoamine oxidase inhibition in a patient with type 1 diabetes

2016 ◽  
Vol 14 (2) ◽  
pp. 163-165 ◽  
Author(s):  
Hamlin Emory ◽  
Neptune Mizrahi
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Monoamine Oxidase ◽  
Monoamine Oxidase Inhibitor ◽  
Combined Treatment ◽  
Insulin Regimen ◽  
Imaging Data ◽  
Monoamine Oxidase Inhibition ◽  
Oxidase Inhibition

We present clinical, electroencephalographic and low-resolution electromagnetic tomography data that support combined treatment with insulin and a monoamine oxidase inhibitor in a patient with type 1 diabetes. We suggest that brain imaging data can identify a subgroup of patients who are likely to benefit from an insulin regimen and monoamine oxidase inhibition to improve glycaemic control, cardiovascular function, normalize the circadian rhythm and restore perception of glycaemic awareness.

Sign in / Sign up

Export Citation Format

Share Document